ERBB2 and breast cancer: Prosigna (PAM50), yet another important panel utilising gene expression tests, assesses the expression of 50 genes to classify breast cancer into one of four intrinsic subtypes: Luminal A, Luminal B, HER2-enriched, and Basal-like (Figure 5).